Michael J. Fox Leads Parkinson's Disease Advocates On Capitol Hill
Author: Michael J. Fox Foundation(i) : Contact: michaeljfox.org
Published: 2017-03-01 : (Rev. 2018-03-15)
Synopsis and Key Points:
Michael J. Fox leads more than 200 parkinsons disease advocates on Capitol Hill in support of federal research funding and access to care.
As part of The Michael J. Fox Foundation for Parkinson's Research (MJFF) 2017 Parkinson's Policy Forum, Michael J. Fox met with bipartisan members of the House of Representatives today to urge lawmakers to support policies that safeguard federal research funding and access to care for the more than 1 million Americans living with Parkinson's disease (PD).
"Our Foundation is grateful for the effort, farsightedness and integrity of the members of Congress and their staff who took the time to hear from the nationwide Parkinson's community today - 200 individuals representing 43 states," said Michael J. Fox. "We stand ready to work together to preserve critical federal funds for research and ensure access to health care for everyone living with Parkinson's."
Michael J. Fox (second from the right) meets with bipartisan members of the House of Representatives on Capitol Hill in Washington, D.C., Tuesday, February 28, 2017. Photo Credit: The Michael J. Fox Foundation - Joe Shymanski
The following members of the House of Representatives were in attendance: Rep. Gus Bilirakis (R-FL), Rep. Michael Burgess, MD (R-TX), Rep. Rodney Frelinghuysen (R-NJ), Rep. Gene Green (D-TX), Rep. Nita Lowey (D-NY), Rep. Frank Pallone, Jr. (D-NJ), Rep. Nancy Pelosi (D-CA), Rep. Phil Roe, MD (R-TN), Rep. Steve Scalise (R-LA), Rep. Pat Tiberi (R-OH) and Rep. Fred Upton (R-MI).
Fox's meeting took place on the Foundation's Hill Day as part of the 2017 Parkinson's Policy Forum, where 200 people living with Parkinson's and caregivers from across the country met with lawmakers on the Hill to discuss key issues impacting the Parkinson's community.
The Forum brought together Foundation leadership and advocates to discuss the current Parkinson's policy landscape, honor distinguished PD advocates and mobilize Hill Day activities to educate Congress on legislative issues that matter most to those affected by Parkinson's disease.
Parts of the Forum were live streamed via Facebook Live and can be accessed on MJFF's Facebook page.
Since inception, MJFF has invested more than $700 million in Parkinson's research, complementing federal funding, which is imperative to drive progress in drug and device development from basic research through FDA approval. In addition to supporting continued and increased federal funding for research, MJFF's other policy priorities include federal support for drug development and approvals, and safeguarding access to care and support.
To learn more about MJFF's work in public policy, visit www.michaeljfox.org/policy
(i)Source/Reference: Michael J. Fox Foundation. Disabled World makes no warranties or representations in connection therewith. Content may have been edited for style, clarity or length.
- 1: Soap, Cleaning the World and Saving Lives : Disabled World (2014/10/02)
- 2: MercyCorps Organization Overview : Thomas C. Weiss (2015/10/19)
- 3: The LD Resources Foundation : Thomas C. Weiss (2013/03/04)
- 4: Initiative by Afford Promises All Australians Access to Disability Supports in Response to COVID-19 : The Australian Foundation for Disability (Afford) (2020/04/17)
- 5: List of Disability Organizations : Disabled World (2011/04/19)
- 6: The Amity Foundation: Assistance for Drug or Alcohol Abuse : Thomas C. Weiss (2015/07/21)
- 7: Susan G. Komen Breast Cancer Foundation : Sally Hayes (2009/02/19)
• Disabled World is strictly a news and information website provided for general informational purpose only and does not constitute medical advice. Materials presented are in no way meant to be a substitute for professional medical care by a qualified practitioner, nor should they be construed as such. Any 3rd party offering or advertising on disabled-world.com does not constitute endorsement by Disabled World. Please report outdated or inaccurate information to us.